Karger, Amy B.; Brien, James D.; Christen, Jayne M.; Dhakal, Santosh; Kemp, Troy J.; Klein, Sabra L.; Pinto, Ligia A.; Premkumar, Lakshmanane; Roback, John D.; Binder, Raquel A.; Boehme, Karl W.; Boppana, Suresh; Cordon-Cardo, Carlos; Crawford, James M.; Daiss, John L.; Ii, Alan P. Dupuis; Espino, Ana M.; Firpo-Betancourt, Adolfo; Forconi, Catherine; Forrest, J. Craig; Girardin, Roxie C.; Granger, Douglas A.; Granger, Steve W.; Haddad, Natalie S.; Heaney, Christopher D.; Hunt, Danielle T.; Kennedy, Joshua L.; King, Christopher L.; Krammer, Florian; Kruczynski, Kate; LaBaer, Joshua; Lee, F. Eun-Hyung; Lee, William T.; Liu, Shan-Lu; Lozanski, Gerard; Lucas, Todd; Mendu, Damodara Rao; Moormann, Ann M.; Murugan, Vel; Okoye, Nkemakonam C.; Pantoja, Petraleigh; Payne, Anne F.; Park, Jin; Pinninti, Swetha; Pinto, Amelia K.; Pisanic, Nora; Qiu, Ji; Sariol, Carlos A.; Simon, Viviana; Song, Lusheng; Steffen, Tara L.; Stone, E. Taylor; Styer, Linda M.; Suthar, Mehul S.; Thomas, Stefani N.; Thyagarajan, Bharat; Wajnberg, Ania; Yates, Jennifer L.; Sobhani, Kimia

Impact of Obesity on Vaccination to SARS-CoV-2

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-06-2031

OAAI

Requirement for robust T and B cell responses for immune protection against Powassan virus (POWV) in virus-like particle (VLP) vaccination.

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Balanced T and B cell responses are required for immune protection again st Powassan virus in virus-like particle vaccination

CELL REPORTS

IF6.9

2022-02-0110

OAAI

Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination

VIRUSES-BASEL

IF3.5

2021-09-3021

OAAI

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-09-068

OAAI

Obesity Enhances Disease Severity in Female Mice Following West Nile Virus Infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-3112

OAAI

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

单剂量鼻内给药AdCOVID可引起针对SARS-CoV-2的全身和粘膜免疫，并充分保护小鼠免受致死性攻击

VACCINES

IF3.4

2021-08-0971

OAAI

King, R. Glenn; Silva-Sanchez, Aaron; Peel, Jessica N.; Botta, Davide; Dickson, Alexandria M.; Pinto, Amelia K.; Meza-Perez, Selene; Allie, S. Rameeza; Schultz, Michael D.; Liu, Mingyong; Bradley, John E.; Qiu, Shihong; Yang, Guang; Zhou, Fen; Zumaquero, Esther; Simpler, Thomas S.; Mousseau, Betty; Killian, John T., Jr.; Dean, Brittany; Shang, Qiao; Tipper, Jennifer L.; Risley, Christopher A.; Harrod, Kevin S.; Feng, Tsungwei; Lee, Young; Shiberu, Bethlehem; Krishnan, Vyjayanthi; Peguillet, Isabelle; Zhang, Jianfeng; Green, Todd J.; Randall, Troy D.; Suschak, John J.; Georges, Bertrand; Brien, James D.; Lund, Frances E.; Roberts, M. Scot

Amelia K. Pinto

个人简介

教育背景

工作经历

荣誉奖项

研究方向